期刊文献+

2015年云南省个旧市恶性肿瘤流行情况分析 被引量:5

Analysis of Cancer Incidence and Mortality in Gejiu City of Yunnan Province,2015
原文传递
导出
摘要 [目的]分析2015年云南省个旧市恶性肿瘤的发病和死亡情况。[方法]评估个旧市2015年恶性肿瘤登记数据质量,计算恶性肿瘤发病(死亡)率、年龄别发病(死亡)率、标化发病(死亡)率、截缩发病(死亡)率、累积发病(死亡)率和前10位恶性肿瘤构成等指标。标准人口采用2000年全国人口普查数据和Segi’s世界标准人口。[结果] 2015年个旧市登记数据的病理诊断比例(MV%)为69.82%,只有死亡医学证明书比例(DCO%)为4.17%,死亡/发病比(M/I)为0.67。2015年个旧市恶性肿瘤粗发病率为228.96/10万,中标发病率为145.29/10万,世标率为140.30/10万,截缩率为236.45/10万,累积发病率(0~74岁)为16.73%。2015年个旧市恶性肿瘤粗死亡率为153.16/10万,中标死亡率为90.89/10万,世标率为89.62/10万,截缩率为127.83/10万,累积死亡率(0~74岁)为10.52%。发病前10位恶性肿瘤依次为肺癌、结直肠癌、女性乳腺癌、肝癌、甲状腺癌、胃癌、膀胱癌、淋巴瘤、宫颈癌和子宫体癌,占全部恶性肿瘤发病的73.31%。死亡前10位恶性肿瘤依次为肺癌、结直肠癌、肝癌、胃癌、膀胱癌、白血病、胆囊癌、女性乳腺癌、淋巴瘤和食道癌,占全部恶性肿瘤死亡的78.11%。[结论]肺癌、消化系统恶性肿瘤和女性乳腺癌是威胁个旧市居民的主要恶性肿瘤,应重点防治。男性应作为个旧市膀胱癌防治工作的重点对象。 [Purpose]To analyze the cancer incidence and mortality in Gejiu City in 2015.[Methods]The data quality of malignant tumor registration in Gejiu City in 2015 was evaluated.The crude incidence/mortality rates,age-specified incidence/mortality rates,age-standardized incidence/mortality rates,the truncated age-standardized incidence/mortality rates,cumulative incidence/mortality rates and the proportion of top 10 cancers were calculated.Chinese population census in 2000 and Segi’s population were used for age-standardized rates(ASR China,ASR world).[Results]In registration data from Gejiu City in 2015,the morphology verified cases(MV%)accounted for 69.82%,and 4.17%of incident cases were identified through death certifications only(DCO%)with a mortality to incidence ratio(M/I)of 0.67.The crude incidence rate of malignant tumor in Gejiu City in 2015 was 228.96/10^5,the incidence ASR China was 145.29/10^5 and by ASR world was 140.30/10^5.The truncated incidence ASR world was 236.45/10^5,and the accumulative incidence rate was 16.73%.The crude mortality rate of malignant tumor in Gejiu city in 2015 was 153.16/10^5,the mortality ASR China was 90.89/10^5 and ASR world was 89.62/10^5.The truncated mortality ASR world was 127.83/10^5,and the accumulative mortality rate was 10.52%.The top ten common cancer types were lung cancer,colorectal cancer,female breast cancer,liver cancer,thyroid cancer,gastric cancer,bladder cancer,lymphoma,cervical cancer and uterine cancer,accounting for 73.31%of all cancer cases.Lung cancer,colorectal cancer,liver cancer,gastric cancer,bladder cancer,leukemia,gallbladder cancer,female breast cancer,lymphoma and esophagus cancer were the most common for cancer deaths,accounted for 78.11%of all cancer deaths.[Conclusions]Lung cancer,malignant tumor in the digestive system and female breast cancer are still the major cancer burden in residents in Gejiu.Prevention and control and epidemiological investigation of these cancers should be strengthened.Men should be the main population for bladder cancer prevention in Gejiu.
作者 王建宁 成会荣 秦明芳 苗雅 王卫民 周清 胡志伟 潘龙海 文卫华 陈杨 WANG Jian-ning;CHENG Hui-rong;QIN Ming-fang;MIAO Ya;WANG Wei-min;ZHOU Qing;HU Zhi-wei;PAN Long-hai;WEN Wei-hua;CHEN Yang(Gejiu Municipal Leading Group Office of Cancer Prevention and Control,Gejiu 661400,China;Yunnan Center for Disease Prevention and Control,Kunming 650022,China;Gejiu Municipal Health Bureau,Gejiu 661400,China)
出处 《中国肿瘤》 CAS CSCD 北大核心 2020年第10期725-730,共6页 China Cancer
基金 国家自然科学基金(81160343、30860238)。
关键词 肿瘤登记 恶性肿瘤 发病率 死亡率 云南 cancer registration malignant tumor incidence mortality Yunnan
  • 相关文献

参考文献12

二级参考文献125

  • 1QING-WENMA,GUO-FANGLIN,JI-GANGCHEN,CUI-QINGXIANG,WEI-CHAOGUO,KLAUSGOLKA,JIAN-HUASHEN.Polymorphism of N-acetyltransferase 2 (NAT2) Gene Polymorphism in Shanghai population: Occupational and Non-occupational Bladder Cancer Patient Groups[J].Biomedical and Environmental Sciences,2004,17(3):291-298. 被引量:13
  • 2姚树祥,晋萍,范亚光,吴锡南,黄玉辉,杨兰,常润生,姚明鉴,乔友林.云南锡矿工人肺癌高发的流行病学调查(1954~2002年)[J].环境与职业医学,2007,24(5):465-468. 被引量:23
  • 3Akarolo-Anthony 5N, Ogundiran TO, Adebamowo CA. Emerging breast cancer epidemic: evidence from Africa[J]. Breast Cancer Res, 2010, 12(Suppl 4):S8.
  • 4Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer[J]. N Engl Med, 2005, 353(17):1784-1792.
  • 5Sant M, Allemani C, Berrino F, et al. Breast cancer survival in Europe and the United State s[J]. Cancer, 2004, 100(8):715-722.
  • 6Olsen AH, Nijor SH, Vejborg I, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort studv[J], BMJ, 2005, 330(7485):220.
  • 7Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta-analysis[J]. AMA, 1995,273(2):149-154.
  • 8Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised triats[J]. Lancet, 2002, 359(9310):909-919.
  • 9Miller AB. Screening for breast cancer with mammography[J]. Lancet, 2001, 358(9299):2164.
  • 10Mushlin AI, Kouides RW, Shapiro DE. Estimating the accuracy of screening mammography: a meta-analysis[J]. AmJ Prev Med, 1998, 14(2):143-153.

共引文献1200

同被引文献60

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部